BioSpace News Archive

Tranquis Therapeutics today announced it has strengthened its management team with the addition of Faisal Shawwa, MBA, as Senior Vice President of Finance and Administration and Janet Hurt, MPH, as Senior Vice President of Clinical Evidence Generation.

Suono Bio, Inc. today announced it has entered into an exclusive world-wide patent license with Massachusetts Institute of Technology (MIT), Brigham and Woman’s Hospital, and Massachusetts General Hospital.

Eurofins Environment Testing Launches PFAS Exposure™ Self-Collection Blood Test.

Conference Call and Webcast Scheduled for Monday, December 13, 2021 at 1:30 PM PT/4:30 PM ET.

POINT Biopharma Global Inc., a company accelerating the discovery, development, and global access to life changing radiopharmaceuticals, announced changes to its senior leadership team as well as its Board of Directors.

Regulus Therapeutics Inc. today announced a presentation at the first annual Rare & Genetic Kidney Disease Drug Development Summit.

GlaxoSmithKline plc launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community.

Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced it has launched its EsoGuard Telemedicine Program in partnership with UpScriptHealth, a leading, nationwide, direct-to-consumer telemedicine company.

Excess fat accumulation in the liver is detrimental to health and can lead to liver cancer. Given the link between this condition and alcohol consumption, the presence of fatty livers in individuals who don’t consume large amounts of alcohol was termed “non-alcoholic fatty liver disease” or NAFLD in the 1980s.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects the Omicron COVID-19 variant (B.1.1.529).